Conference MDAngle: CMSC 2024 Multiple Sclerosis

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

The Consortium of Multiple Sclerosis Centers (CSMC) Annual Meeting took place in Nashville, Tennessee from May 29 to June 1. The meeting featured symposia, roundtables, clinical courses, and workshops in MS care over 4 days. Renowned experts led accredited education sessions on comprehensive care, disease modification, research, mental health, rehabilitation, and wellness.

Carrie Hersh, DO, MSc

Associate Professor of Neurology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio; Director of Multiple Sclerosis Health and Wellness Program, Associate Program Director, MS Fellowship, Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada

"The CMSC 2024 Annual Meeting offered comprehensive clinical insights that can enhance patient management practices, emphasizing the integration of new technologies, the importance of medication adherence, the effectiveness of various treatments in real-world practice and in more diverse patient populations, and addressing systemic challenges within the healthcare system."

Annalisa Morgan, MD

Clinical Fellow, Yale School of Medicine, New Haven, Connecticut

"Now having had some more time to reflect on what I heard at CMSC this year, I think that where some of this data will influence my clinical practice the most is in our patients with new-onset, highly inflammatory relapsing-remitting multiple sclerosis. And like most providers in the United States, I tend to favor an early high-efficacy therapy approach in these patients from multiple perspectives, including efficacy, side-effect profile, convenience, and family planning considerations."

Preconference Considerations

CMSC 2024: Approaching New Horizons in Multiple Sclerosis Care

Dr Hersh previews the 2024 CMSC Annual Meeting, featuring Dr Darin T. Okuda's John F. Kurtzke Memorial Lecture challenging MS perceptions, and Dr Fred Lublin's Presidential Lecture reflecting on 30 years of MS therapy. Presentations will cover real-world effectiveness of therapies, pediatric MS, aging populations, and safety concerns, including studies like CHIMES study. The event will also highlight multidisciplinary MS care through rehabilitation projects and initiatives for patient education and symptom management.

Quick Clinical Takeaways

Highlights and Insights From CMSC 2024

Dr Morgan reports from the CMSC Annual Meeting, highlighting the adoption of innovative approaches in MS treatment. Key discussions included Dr Darin T. Okuda’s lecture on rethinking current knowledge in MS to spark innovation, the effectiveness of early high-efficacy therapies, and strategies for treating NMOSD and MOGAD, with a focus on acute and maintenance therapies.

How Will My Patients Benefit?

Insights Into Multiple Sclerosis Care Through the Lens of CMSC 2024

Dr Hersh reflects on how the 2024 Annual Meeting of the Consortium of Multiple Sclerosis Centers highlighted the increasing role of artificial intelligence in MS management and emphasized strategies for medication adherence. Discussions on medication safety and efficacy, along with innovative approaches like at-home phototherapy, underscored the meeting's focus on advancing patient care and addressing systemic challenges within the MS community.

Polling Question

Summary

Dr Morgan and Dr Hersh reflect on the 2024 CMSC Annual Meeting, highlighting key discussions and innovative approaches in MS treatment. Dr Darin T. Okuda's lecture challenged current MS perceptions to drive innovation, while Dr Fred Lublin reviewed 30 years of MS therapy. The meeting covered the real-world effectiveness of therapies, pediatric MS, aging populations, and safety concerns from the CHIMES study. Emphasis was placed on early high-efficacy therapies, strategies for treating NMOSD and MOGAD, and the increasing role of artificial intelligence in MS management. Multidisciplinary care, patient education, symptom management, and strategies for medication adherence and safety were also central themes.

Resources:

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Conference MDAngle: CMSC 2024 Multiple Sclerosis - Medscape - May 21, 2024.

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

My Alerts